1. Home
  2. ACR vs BNR Comparison

ACR vs BNR Comparison

Compare ACR & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$17.62

Market Cap

146.1M

Sector

Real Estate

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$9.60

Market Cap

119.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACR
BNR
Founded
2005
2014
Country
United States
China
Employees
4
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.1M
119.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ACR
BNR
Price
$17.62
$9.60
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$24.50
N/A
AVG Volume (30 Days)
42.5K
23.0K
Earning Date
04-30-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$111.65
Revenue Next Year
N/A
N/A
P/E Ratio
$19.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.61
$4.75
52 Week High
$24.61
$41.72

Technical Indicators

Market Signals
Indicator
ACR
BNR
Relative Strength Index (RSI) 49.27 49.22
Support Level $17.34 $8.00
Resistance Level $19.64 $13.39
Average True Range (ATR) 0.46 0.95
MACD 0.10 0.19
Stochastic Oscillator 57.89 40.37

Price Performance

Historical Comparison
ACR
BNR

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: